Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LiRIS 400 mg for Interstitial Cystitis
NCT01824303Phase 2Terminated
- Sponsor
- Allergan
- Start
- Mar 2013
- Primary completion
- Nov 2014
- Countries
- 2
01
Overview
A Phase 2 trial of lidocaine-releasing intravesical system in interstitial cystitis (IC), sponsored by Allergan. Started Mar 2013; status: terminated.
02
Drugs
lidocaine-releasing intravesical system
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT01824303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01824303.